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BRIEF REPORTS
Abstract: We report on a mother-to-child transmission of KPC carbapen-
emase-producing Klebsiella pneumoniae at birth followed by subsequent 
cases in the neonatal intensive care unit. Molecular analysis of isolates 
showed production of KPC-3 enzyme. The only potential risk factor identi-
fied for the mother was previous activity as a caregiver. Present findings 
suggest consideration of proactive surveillance in pregnant women with risk 
factors for colonization.
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The recent dissemination of carbapenem-resistant Klebsiella pneumoniae (CR-Kp) is a major public health challenge, 
because of the limited treatment options and the remarkable poten-
tial for dissemination of CR-Kp in healthcare settings.1 Carbapen-
emase production is the most important mechanism of resistance in 
CR-Kp, with a number of different types of enzymes involved (e.g., 
KPC, IMP, VIM, NDM and OXA-48).2 KPC-type carbapenemases 
are among the most widespread, and KPC carbapenemase-produc-
ing K. pneumoniae (KPC-Kp) lineages, such as those of clonal 
complex 258, have caused large outbreaks and spread epidemically 
in several countries.1 Italy is one of these countries, where the rates 
of CR-Kp causing invasive infections increased from 0.9% in 2009 
to 32.9% in 2014,3 mostly because of a countrywide dissemination 
of KPC-Kp of clonal complex 258.4
Infections caused by KPC-Kp are typically healthcare-asso-
ciated. Most of these infections are reported in adult and elderly 
patients, but pediatric patients can also be involved after exposure 
to healthcare practices.5,6 Here we report the first case of KPC-
Kp infection occurring in an extremely low birth weight (ELBW) 
infant after perinatal transmission of the resistant pathogen, and 2 
subsequent cases in the neonatal intensive care unit (NICU).
CASE REPORT
On April 2014, a 30-year-old woman, 22 weeks pregnant, 
was admitted to the A. Manzoni Hospital of Lecco (northern Italy) 
for a preterm premature rupture of membranes. The woman was 
citizen of Sri Lanka, but had been living in Italy since several years 
and had been working as a private caregiver. No recent travel to 
Sri Lanka was referred. The clinical conditions were good, with no 
fever or signs of sepsis. Ampicillin (2 g every 6 hours) and clarithro-
mycin (500 mg every 12 hours) were given for 6 days, in accord-
ance with guidelines for the management of women with preterm 
premature rupture of membranes.7 In the 23rd week of pregnancy, 
vaginal delivery was performed because labor had started. The 
infant was an ELBW male of 540 g; the APGAR score was 5 at 
1 minute after birth. An endotracheal tube was inserted, assisted 
ventilation was started, and the infant was admitted to the hospi-
tal’s NICU. Diagnosis of respiratory distress syndrome was made, 
based on a chest radiograph. Routine microbiologic screening for 
preterm infants, including throat, and auricular swabs, yielded a 
CR-Kp isolate from the upper airways. Routine culture of the pla-
centa specimen collected at birth was also positive for a CR-Kp. 
A rectal swab subsequently obtained from the mother showed that 
she was colonized by CR-Kp. The CR-Kp isolates were resistant to 
all tested antibiotics with the exception of gentamicin, and colistin, 
according to EUCAST criteria (see Table 1 for minimal inhibitory 
concentration values). Molecular testing by GeneXpert instrument 
(Xpert Carba-R, Cepheid, Sunnivale, CA) was positive for the KPC 
carbapenemase gene. Eight days after delivery, the newborn showed 
laboratory signs of sepsis including leukocytosis (37,200/μL) and 
platelet count decrease (62,000/μL). CR-Kp with the same resist-
ance profile and KPC positivity by molecular testing were isolated 
from blood and the bronchial aspirate. Treatment with meropenem 
(20 mg/kg every 8 hours) plus colistin (2.5 mg/kg twice daily) was 
given for 10 days. The antibiotic regimen was well-tolerated and 
clinical conditions rapidly improved.
Twenty-four days after delivery, the newborn developed a 
new episode of sepsis caused by Serratia marcescens and Entero-
coccus faecalis showing wild-type antimicrobial susceptibility pat-
terns. This new episode was successfully treated with cefotaxime 
(50 mg/kg every 8 hours), gentamicin (2.5 mg/kg every 24 hours) 
and ampicillin (50 mg/kg every 6 hours) administered for 10 days.
During subsequent hospital stay, KPC-Kp was persistently 
detected in surveillance rectal swabs, but not from other sites. The 
child was discharged after 115 days, in good clinical conditions 
(2590 g). A rectal swab, performed 1 year after discharge, as a part 
of the follow-up program, was negative for CR-Kp.
Further molecular analysis of the CR-Kp isolates, carried 
out as described previously,4 revealed that they produced a KPC-3 
enzyme, exhibited identical pulsed-field gel electrophoresis pro-
files after macrorestriction analysis with XbaI, and belonged in 
sequence type 512. No other carbapenemase genes were detected 
(including those encoding VIM-type, IMP-type, NDM-type and 
OXA-48-type enzymes), nor ESBL genes encoding TEM-type, 
SHV-type and CTX-M-type enzymes.
Until this case, no CR-Kp or other carbapenem-resistant 
enterics had been isolated from NICU patients of this hospital. 
After detection of the first CR-Kp isolate, this newborn was imme-
diately isolated and a separate staff was dedicated to his care. Sur-
veillance rectal swabs were obtained at admission and on a weekly 
basis from all infants admitted to the NICU. Forty-five days after 
admission of the index patient, 2 other infants were found to be 
colonized by CR-Kp showing identical features and pulsed-field 
gel electrophoresis profiles (Fig., Supplemental Digital Con-
tent 1, http://links.lww.com/INF/C595). Both infants had a low 
birth weight and remained colonized at the intestinal level with-
out developing infections. A dedicated infection control team was 
established for investigating the outbreak and instituting additional 
precautionary control measures. Several meetings (commonly on 
weekly basis) were hold to provide an adequate response and to 
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monitor the epidemiologic situation. Strict infection control meas-
ures were adopted. First of all, colonized neonates were placed in 
isolation in a separate box, with a higher spacing between cots, and 
managed with dedicated nursing staff (2 nurses for 3 infants). Other 
measures such as improvement of hand hygiene compliance and 
deep cleaning of environment and equipment were adopted. At the 
same time, following the consequent reduction of available cots, 
a temporary restriction of admissions to the NICU was decided, 
communicated across the neonatal regional network and applied 
for about 2 months. High-risk pregnant women were redirected 
to other regional hospitals of the network. No additional cases 
of CR-Kp or other carbapenem-resistant enterics were thereafter 
detected in the NICU.
DISCUSSION
The paper describes a case of mother-to-child transmission 
at birth in a ELBW infant, followed by a KPC-Kp bloodstream 
infection and a subsequent transmission to other 2 NICU patients. 
The route of transmission was supported by the timing of culture 
positivity, by the fact that the mother was found to be colonized by 
the same strain, and by the absence of circulating KPC-Kp in the 
NICU before admission of the index case.
This way of transmission is a well-known cause of newborn 
infection with several pathogens, including Streptococcus agalac-
tiae and Enterobacteriaceae. S. agalactiae, a common gut inhabit-
ant, plays a pivotal role as a cause of neonatal bacterial meningitis, 
requiring the routine implementation of a screening rectal swab in 
the last month of pregnancy and, in case of maternal colonization, 
an appropriate antimicrobial prophylaxis at birth.8 Furthermore, in 
the case of maternal colonization with ESBL-producing entero-
bacteria (that are challenging because of their multidrug resistance 
phenotypes), mother-to-child transmission has been demonstrated 
to be an important risk factor for colonization of very low birth 
weight infants, leading to potential epidemics in NICUs. As a con-
sequence, routine screening of neonates and mothers has been pro-
posed as a means of reducing neonatal morbidity and mortality.9 
Similarly, present findings would suggest to consider, in endemic 
areas, a proactive surveillance for carbapenem-resistant enterics 
colonization in pregnant women with risk factors for colonization. 
In our case, the epidemiologic analysis showed, as the only poten-
tial risk factor, that the woman had worked since some years as a 
caregiver. No other risk factors (e.g., previous hospitalization in the 
last 2 years, prolonged use of broad-spectrum antibiotics, clinical 
conditions affecting the immune system) were found.
The presence of a newborn positive for a KPC-Kp strain 
and the subsequent outbreak posed a multifaceted challenge to 
the healthcare system. With regard to infection control issues, out-
breaks of CR-Kp in NICUs could become an emerging problem in 
settings of high endemicity.10 The implementation of strict infection 
control measures enabled us to limit the outbreak, yet the manage-
ment of the epidemic required a huge effort in terms of time, direct 
and indirect costs, and jeopardized the functioning of the neonatal 
regional network.
From a clinical point of view, little is known about the out-
come of sepsis caused by CR-Kp in infants, particularly with low 
birth weight. Treatment of bloodstream infections in newborns is 
still a challenge. Symptoms of sepsis in preterm neonates are often 
difficult to recognize. Nevertheless, antibiotic therapy should be 
promptly administered, and should be appropriate for the pathogen 
and safe for the newborn. In our case, early administration of a 
colistin-based regimen was able to cure the infection, but it prob-
ably contributed to the onset of the subsequent sepsis by S. marces-
cens, a microorganism intrinsically not susceptible to polymyxins. 
Concerns about intravenous colistin use in adults are related to its 
high toxicity. Data regarding its usage in neonates with ELBW are 
very limited. In the case we report, colistin treatment was effective 
and well-tolerated.
To our best knowledge, this is the first description of a 
mother-to-child transmission of KPC-Kp at birth. Based on our 
experience, in countries with high CR-Kp endemicity, proactive 
surveillance procedures could be considered in pregnant women 
having risk factors for CR-Kp colonization.
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TABLE 1. Susceptibility Profile of KPC-producing K. 
pneumoniae Isolates
Antimicrobial Agent MIC (mg/L)* Interpretation†
Ampicillin >16 R
Amoxicillin–clavulanate >16 R
Piperacillin >128 R
Piperacillin–tazobactam >128 R
Cefotaxime >32 R
Ceftazidime >32 R
Cefepime >32 R
Ertapenem >4 R
Imipenem >8 R
Meropenem >8 R
Ciprofloxacin >2 R
Gentamicin ≤1 S
Amikacin 16 I
Colistin ≤0.5 S
Trimethoprim–sulfamethoxazole >8/152 R
*MIC values as measured by the Vitek system (bioMérieux, Marcy l’Etoile, France).
†Interpretation based on current EUCAST criteria (http://www.eucast.org).
MIC indicates minimal inhibitory concentration.
